Showing results (251-260 of 274) with videos related to
Sort By:
Pageof 28
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 15, 2020
Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic reviewTerry L Ng, Megan M Tu, Mohammed F K Ibrahim, et al.Brazilian Journal of Biology = Revista Brasleira De Biologia|August 25, 2021
Comparison of different diagnostic modalities for isolation of Mycobacterium Tuberculosis among suspected tuberculous lymphadenitis patientsN Sharif, D Ahmed, R T Mahmood, et al.Saudi Journal of Biological Sciences|November 26, 2019
The genetic association study of TP53 polymorphisms in Saudi obese patientsJamal S M Sabir, Abdelfatteh El Omri, Noor A Shaik, et al.AMB Express|January 29, 2025
Celastrol boosts fluconazole efficacy against vaginal candidiasis: in vitro and in vivo evidenceFatma Al-Zahraa A Yehia, Hisham A Abbas, Tarek M Ibrahim, et al.Pharmaceutics|April 16, 2020
Optimized Icariin Phytosomes Exhibit Enhanced Cytotoxicity and Apoptosis-Inducing Activities in Ovarian Cancer CellsNabil A Alhakamy, Usama A Fahmy, Shaimaa M Badr-Eldin, et al.Pharmaceutics|February 24, 2024
RETRACTED: Alhakamy et al. Optimized Icariin Phytosomes Exhibit Enhanced Cytotoxicity and Apoptosis-Inducing Activities in Ovarian Cancer Cells. Pharmaceutics 2020, 12, 346Nabil A Alhakamy, Usama A Fahmy, Shaimaa M Badr-Eldin, et al.Nanomaterials (Basel, Switzerland)|January 22, 2024
RETRACTED: Ahmed et al. Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route. Nanomaterials 2020, 10, 1270Osama A A Ahmed, Usama A Fahmy, Shaimaa M Badr-Eldin, et al.Nanomaterials (Basel, Switzerland)|July 3, 2020
Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal RouteOsama A A Ahmed, Usama A Fahmy, Shaimaa M Badr-Eldin, et al.Current Oncology (Toronto, Ont.)|August 28, 2024
A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast CancerSharon F McGee, Mark Clemons, Gregory Pond, et al.Pharmaceutics|February 24, 2024
RETRACTED: Awan et al. The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells. Pharmaceutics 2020, 12, 597Zuhier A Awan, Usama A Fahmy, Shaimaa M Badr-Eldin, et al.Pageof 28